|
ALVO
|
Alvotech
|
US
|
NASDAQ
|
|
EHAB
|
Enhabit, Inc.
|
US
|
NYSE
|
|
ENTX
|
Entera Bio Ltd.
|
US
|
NASDAQ
|
|
KROS
|
Keros Therapeutics, Inc.
|
US
|
NASDAQ
|
|
LGND
|
Ligand Pharmaceuticals Incorporated
|
US
|
NASDAQ
|
|
LLY
|
Eli Lilly and Company
|
US
|
NYSE
|
|
QDEL
|
Quidel Corporation
|
US
|
NASDAQ
|
|
RANI
|
Rani Therapeutics Holdings, Inc.
|
US
|
NASDAQ
|
|
TXMD
|
TherapeuticsMD, Inc.
|
US
|
NASDAQ
|
|
ALPMF
|
Astellas Pharma Inc
|
US
|
OTC
|
|
ALPMY
|
Astellas Pharma Inc
|
US
|
OTC
|
|
CHJTF
|
CSPC Pharma Group
|
US
|
OTC
|
|
CMPD
|
Compumed Inc
|
US
|
OTC
|
|
DSKYF
|
Daiichi Sankyo Company, Limited
|
US
|
OTC
|
|
DSNKY
|
Daiichi Sankyo Company, Limited
|
US
|
OTC
|
|
ESALF
|
Eisai Co Ltd
|
US
|
OTC
|
|
ESALY
|
Eisai Co Ltd Spons A
|
US
|
OTC
|
|
LGNDZ
|
Ligand Pharma
|
US
|
OTC
|
|
LGNXZ
|
Ligand Pharma
|
US
|
OTC
|
|
LGNYZ
|
Ligand Pharma
|
US
|
OTC
|